Hadean Ventures is a Norway-based venture capital firm that focuses on investing in early-stage life science companies across Europe and the United States. Their strategy involves providing funding and strategic support to startups developing innovative solutions in pharmaceuticals, biotechnology, medical technology, diagnostics, and digital health, with an emphasis on products addressing unmet medical needs.
100% of their portfolio is in Biotech & Life Sciences. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (60% of deals). Average disclosed round size is $64.2M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$230M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Step Pharma | Series C | $38M | Oct 2025 |
 ARTHEx Biotech S.L. | Series B | $87M | Sep 2025 |
 SciRhom GmbH | Series A | $70M | Jul 2024 |
 TargED Biopharmaceuticals | Series A | $39M | Feb 2022 |
 Emergence Therapeutics AG | Series A | $87M | Dec 2021 |
Top Co-Investors
Last updated: 7 April 2026